American Association of Tissue Banks

ACE SOUTHERN Announces Strategic Supply Partnership with U.S. Oral Surgery Management

Retrieved on: 
Thursday, August 31, 2023
Foam, Partnership, Surgeon, Public sector banks in India, Plasma protein binding, GM, Patient, ACE, Oral and maxillofacial surgery, Oral, American Association of Tissue Banks, Dentistry, Pharmaceutical industry

WEST COLUMBIA, S.C., Aug. 31, 2023 /PRNewswire/ -- ACE SOUTHERN, a leading global provider of Oral Surgery and biomaterial products, and U.S. Oral Surgery Management, a specialty management service company that exclusively serves premier oral and maxillofacial surgeons, are excited to announce a multi-year, first in the industry, comprehensive partnership for Oral Surgery solutions, effective immediately.

Key Points: 
  • WEST COLUMBIA, S.C., Aug. 31, 2023 /PRNewswire/ -- ACE SOUTHERN, a leading global provider of Oral Surgery and biomaterial products, and U.S.
  • Oral Surgery Management, a specialty management service company that exclusively serves premier oral and maxillofacial surgeons, are excited to announce a multi-year, first in the industry, comprehensive partnership for Oral Surgery solutions, effective immediately.
  • ACE SOUTHERN Announces Strategic Supply Partnership with U.S.
  • Oral Surgery Management
    As part of the partnership, ACE SOUTHERN will support USOSM offices with a broad range of surgical supplies, pharmaceuticals, bone grafting, and membrane solutions.

Induce Biologics Announces Launch of NMP Cancellous Strips

Retrieved on: 
Tuesday, February 28, 2023
Biotechnology, Health, Surgery, Medical Devices, NMP, BMA, Surgeon, Public sector banks in India, Temperature, AATB, Blood, American Association of Tissue Banks, PRP, National Baptist Convention, USA, Inc., Phosphorus

The new product is an advanced cancellous bone-graft solution utilizing Induce Biologics’ proprietary Natural Matrix Protein (NMP) process, which unlocks the growth factors naturally found in bone, making them bioavailable.

Key Points: 
  • The new product is an advanced cancellous bone-graft solution utilizing Induce Biologics’ proprietary Natural Matrix Protein (NMP) process, which unlocks the growth factors naturally found in bone, making them bioavailable.
  • NMP Strips, the latest member of Induce Biologics’ NMP product family, feature an optimal strip design providing ideal handling characteristics for fluid retention and expansion.
  • “We are pleased to introduce this new addition to the NMP Bioimplant line,” said David Campagnari, President of Induce Biologics USA.
  • Our launch of the NMP Strip format, in addition to our existing NMP Particulates and NMP Fibers, provides surgeons with another bone-graft option, utilizing Induce Biologics’ proprietary Natural Matrix Protein (NMP) process, which unlocks the growth factors naturally found in bone, making them bioavailable.

The Donate Life Community and its Inspiring “Lifting Each Other Up” Float Invites Audiences to Watch the 2023 Rose Parade January 2

Retrieved on: 
Friday, December 30, 2022
Events, Concerts, Surgery, General Entertainment, Optical, General Health, Philanthropy, Fund Raising, Foundation, Family, Science, Entertainment, Other Philanthropy, Consumer, Other Science, Health, Dignity, Thermo Fisher Scientific, Cedars-Sinai Medical Center, NBC, Medicine, Service Corporation International, Public sector banks in India, CompuMe, Rose, American Association of Tissue Banks, Walkers, Gift, Eye, KTLA, Donate Life America, Transplant, ABC, Gift of Life Marrow Registry, Rural Free Delivery, Tree, Univision, The Bridge: The Life and Rise of Barack Obama, Hospital, Medical device, Peafowl, LifeSharers

On January 2, 2023, the Donate Life community will celebrate 20 years of participation in the Rose Parade® as its inspiring “Lifting Each Other Up,” float makes its way down Colorado Blvd.

Key Points: 
  • On January 2, 2023, the Donate Life community will celebrate 20 years of participation in the Rose Parade® as its inspiring “Lifting Each Other Up,” float makes its way down Colorado Blvd.
  • The 134th annual parade kicks off at 8:00 a.m. PT (11:00 a.m.
  • ET) and it will air on ABC, KTLA 5, NBC, Univision, Peacock, Cowboy Channel, and RFD-TV — or Rural Free Delivery.
  • The centerpiece of the 2023 Donate Life float is a spectacular street dragon which in Asian cultures symbolizes great power, good luck and strength.

Celebrating 20 Years of Rose Parade Participation, The 2023 Donate Life Rose Parade® Float, Lifting Each Other Up Will Honor 59 Organ, Eye and Tissue Donors and Recipients

Retrieved on: 
Tuesday, December 27, 2022
Other Consumer, Surgery, Entertainment, Philanthropy, Events, Concerts, General Entertainment, General Health, Consumer, Health, Foundation, Dignity, Thermo Fisher Scientific, Eye, Multimedia, SC, Coffee, Human, Service Corporation International, AL, Public sector banks in India, Veteran, LifeSharers, CompuMe, Hospital, American Association of Tissue Banks, Walkers, B cell, Transplant, Kidney, Donate Life America, Cornea, EMT, UCLA, Urine, Travel, Patient, The Bridge: The Life and Rise of Barack Obama, Heart, OK, Life, Liver, Toy, Medical device, Tanning (leather), Dentistry, Pharmaceutical industry, Vaccine, Cultured pearl

The Donate Life community is celebrating 20 years of participation in the traditional Rose Parade in Pasadena.

Key Points: 
  • The Donate Life community is celebrating 20 years of participation in the traditional Rose Parade in Pasadena.
  • The 2023 Donate Life Rose Parade® float, “Lifting Each Other Up,” will feature 59 honorees representing 24 states in the United States.
  • View the full release here: https://www.businesswire.com/news/home/20221227005030/en/
    Celebrating 20 Years of Rose Parade Participation, The 2023 Donate Life Rose Parade® Float, Lifting Each Other Up Will Honor 59 Organ, Eye and Tissue Donors and Recipients (Graphic: Business Wire)
    The 2023 Donate Life Float will feature:
    39 floragraphs (floral portraits) representing organ, eye and tissue donors who gave the gift of life to others
    Four honorees whose lives were connected to organ donation will walk alongside the 2023 Donate Life float.
  • These donors gave the ultimate gift of life to save and heal others through the power of organ, eye and tissue donation.

Four Lives Transformed Thanks to the Healing Power of Tissue Donation to be Part of the 2023 Donate Life Rose Parade Float, “Lifting Each Other Up”

Retrieved on: 
Thursday, December 22, 2022
Other Consumer, Surgery, Entertainment, Philanthropy, General Entertainment, General Health, Consumer, Health, Foundation, Other Philanthropy, Public sector banks in India, Infection, Health, Mastectomy, Burn, Breast reconstruction, Breast cancer, Acute myeloid leukemia, Tissue, Pasadena Tournament of Roses Association, CTS, Survivor, Walking, Walkers, Transplant, Eye, Rose Parade, American Association of Tissue Banks, Donate Life America, Hypoesthesia, Tree, Woman, Pharmaceutical industry, Dentistry

The 2023 Donate Life Rose Parade float, Lifting Each Other Up, celebrates the power of organ, eye and tissue donation, with donors and recipients working together to support one another.

Key Points: 
  • The 2023 Donate Life Rose Parade float, Lifting Each Other Up, celebrates the power of organ, eye and tissue donation, with donors and recipients working together to support one another.
  • Thanks to tissue donors, millions of people are healed every year and thousands of lives are saved.
  • The 2023 Donate Life Float tissue recipients include the following float riders and walkers:
    Wendy Dougall.
  • Both Wendy and Thomas’ participation in the 2023 Rose Parade are sponsored by Donate Life South Carolina.

BioStem Technologies Announces Partnership with Kill Cliff FC

Retrieved on: 
Wednesday, December 14, 2022
Public sector banks in India, Physician, Champion, Allotransplantation, MMA, Health, FDA, Regenerative medicine, OTC, Injury, Ultimate, Erosion (morphology), Research, American Association of Tissue Banks, Athlete, COVID-19, AATB, Pharmaceutical industry

POMPANO BEACH, FLORIDA., Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, is pleased to announce that the Company will be a corporate sponsor of Kill Cliff Fight Club (“Kill Cliff FC”), a world-renowned MMA training center based-in Southern Florida.

Key Points: 
  • Kill Cliff FC has more than 80 professional fighters including current and former Champions from the Ultimate Fighting Championship (“UFC”), Bellator MMA, One Championship, and other elite MMA promotions.
  • Under Henri Hooft and Greg Jones, Kill Cliff FC has developed and produced elite fighters such as Michael Chandler, Gilbert Burns, Robbie Lawler, Logan Storley, Aung La Nsang and Gregory Rodrigues.
  • Jason Matuszewski, Chief Executive Officer of BioStem Technologies Inc. said, “The entire team at BioStem is excited for our products to become an integral part of the MMA community.
  • Now BioStem will be associated with some of the biggest moments in MMA.”
    Greg Jones, Co-Founder of Kill Cliff FC, commented “Kill Cliff FC is truly honored to be partnering with BioStem.

BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call

Retrieved on: 
Tuesday, November 15, 2022
COVID-19, OTC, Allotransplantation, Public sector banks in India, Regenerative medicine, Physician, Webcast, Research, AATB, American Association of Tissue Banks, FDA, Risk management

About BioStem Technologies, Inc. (OTC PINK: BSEM):BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies.

Key Points: 
  • About BioStem Technologies, Inc. (OTC PINK: BSEM):BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies.
  • The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method.
  • BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB").
  • Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.

BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer

Retrieved on: 
Wednesday, October 26, 2022
SEC, Company, Accounting, Private Securities Litigation Reform Act, Forward-looking statement, Rutgers University, Controller, IPO, Physician, CPA, Technology, Allotransplantation, Compliance, Regenerative medicine, Public sector banks in India, American Association of Tissue Banks, OTC, American Association, Research, COVID-19, GLOBE, Association, FDA, San Francisco Bay Area, AATB, Health, Security (finance)

Mr. Fortunato brings over 28 years of expert level financial accounting, SEC reporting, M&A and IPO experience to BioStem.

Key Points: 
  • Mr. Fortunato brings over 28 years of expert level financial accounting, SEC reporting, M&A and IPO experience to BioStem.
  • BioStem has made substantial progress and is now reaching an exciting inflection point given our strong commercial momentum, said Jason Matuszewski, Chief Executive Officer of BioStem.
  • Looking at the future of BioStem, having Michael in the role of Chief Financial Officer will help bring the company to the next level given his extensive experience in finance, accounting, and strategic execution.
  • Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.

ALLOSOURCE ANNOUNCES DEAN ELLIOTT AS NEW PRESIDENT AND CEO

Retrieved on: 
Wednesday, October 19, 2022
Cartilage, LLC, Patient, Fascia, Allotransplantation, Transplant, American Association, Association, Board, CEO, Associate, FDA, American Association of Tissue Banks, Empathy, Public sector banks in India, Surgeon, Retirement, Leadership, Pharmaceutical industry, Management, Operation

The AlloSource Board of Directors, in conjunction with an executive recruiting firm, conducted a nation-wide search for the next president and CEO shortly after Tom Cycyota, current AlloSource President and CEO, announced his retirement.

Key Points: 
  • The AlloSource Board of Directors, in conjunction with an executive recruiting firm, conducted a nation-wide search for the next president and CEO shortly after Tom Cycyota, current AlloSource President and CEO, announced his retirement.
  • Elliott, who has served AlloSource as Associate General Counsel, Vice President of Operations, and, most recently, Chief Operating and Legal Officer, will assume his new leadership role on January 9, 2023.
  • "Dean has more than 30 years of experience working in the healthcare industry, and he exemplifies the mission-balance that is engrained in AlloSource's culture," said Diane Brockmeier, AlloSource Board Chair and President and CEO of Mid-America Transplant.
  • Elliott has been with AlloSource since 2003 and brings 30 years of legal, operational, and leadership experience in the healthcare sector.